This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Virtual Event, Worldwide : 28 - 29 January 2025
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Opening words: James Hadfield
Session 1: Horizons for Liquid Biopsy
Session Chair: James Hadfield
KEYNOTE LECTURE
Yuval Dor Hebrew University of Jerusalem, Jerusalem, Israel
Q&A 13:25-13:40
Viktor Adalsteinsson Gerstner Centre for Cancer Diagnostics, Broad Institute, Cambridge, USA
Priming agents transiently attenuate cfDNA clearance to improve liquid biopsies
Q&A 14:00-14:15
Davina Gale AstraZeneca, Cambridge, UK
Q&A 14:35-14:50
REFRESHMENT BREAK
Session 2: Liquid biopsies for breast and lung cancers
Session Chair: Davina Gale
Heather Parsons Dana-Farber Cancer Institute, Boston, USA
Q&A 15:25-15:40
Proffered Paper 1
Q&A 15:50-15:55
Proffered Paper 2
Q&A 16:05 - 16:10
Max Diehn Stanford University School of Medicine, Stanford, USA
Liquid biopsies for detection and characterization of lung cancers
Q&A 16:30-16:45
POSTER SPOTLIGHTS
TRANSITION BREAK
VIRTUAL POSTER SESSION ONE
Listed times are in Central European Time (CET)
VIRTUAL POSTER SESSION TWO
TRANSITION BREAK
WELCOME TO DAY TWO
Session 3: Liquid biopsy in colorectal and bladder cancers
Session Chair: Evi Lianidou
Naureen Starling The Royal Marsden NHS Foundation Trust, London, UK
Circulating nucleic acids (cfDNA/ctDNA): in use, in view and on the horizon’ a GI perspective but with broader applicability
Q&A 14:25-14:40
Silvia Marsoni IFOM, Milan, Italy
'Leveraging liquid biopsy to deconvolute colon cancer biology'
Q&A 15:00-15:15
Lars Dyrskjøt Aarhus University. Aarhus, Denmark
Towards ctDNA-guided treatment of muscle-invasive bladder cancer
Q&A 15:35-15:50
REFRESHMENT BREAK
Session 4: Next generation liquid biopsy researchers
Session Chair: Caroline Dive
Proffered Paper 3
Q&A 16:15-16:25
Proffered Paper 4
Q&A 16:35-16:45
KEYNOTE LECTURE
Victor Velculescu Johns Hopkins University School of Medicine, Baltimore, USA
Q&A 17:05-17:20
DISCUSSION SESSION
Clinical implementation and new technologies
Silvia Marsoni (Chair), IFOM, Milan, Italy; James Hadfield, AstraZeneca, Cambridge, UK; Davina Gale, AstraZeneca, Cambridge, UK
SUMMARY AND CLOSE
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Data
Your details will be retained in our electronic registration database and used for correspondence from the EACR in line with our Privacy Policy.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Don't Share
Share
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
Invoicing information
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
Confirm Registration